drugset / Trial / NCT02466815
A Study to Assess the Relative Bioavailability of JNJ-42756493 Tablets
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to assess the relative bioavailability of 2 prototype G-025 tablets compared with the current G-018 tablet.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erdafitinib | Small molecule | 10 mg | — |
Indications
No indication recorded.